Skip to main content
Market intelligence
AIMHealthcare

AIM ImmunoTech Inc insider activity

In the last 90 days, 1 corporate insider purchased $13,456 of stock on the open market.

SEC-reported filing activity is provided for research purposes and is not investment advice.

90-day C-suite buyers
1
90-day purchase value
$13,456
Corporate buyers
1
Latest transaction
Sep 17, 2026

Executive filings

Open-market transaction history

Purchase and sale summaries are ordered by the latest reported transaction date.

Open-market insider purchase and sale transactions
DateInsider nameRoleTypeSharesPriceTotal value
Sep 17, 2026Thomas K EquelsCEO & PresidentOpen Market Purchase24,000$0.21$4,992
Sep 16, 2026Thomas K EquelsCEO & PresidentOpen Market Purchase11,000$0.21$2,310
Sep 15, 2026Thomas K EquelsCEO & PresidentOpen Market Purchase22,000$0.22$4,862